REBECCA BURNAU: Open Payments
NPI 1538482237 · BENTON HARBOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$688 in 30 payments from 9 companies in 2025. Trend: 2023 $379 · 2024 $870 · 2025 $688
Food & beverage: $579Education: $109
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $162 |
| Teva Pharmaceuticals USA, Inc. | 2 | $124 |
| Neurocrine BioSciences, Inc. | 5 | $93 |
| ABBVIE INC. | 5 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $52 |
| Alkermes, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: FANAPT, INGREZZA, VRAYLAR, COBENFY, ARISTADA, CAPLYTA, SPRAVATO, INVEGA SUSTENNA.
Industry payments across MI — which companies pay providers there.
